PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 9 days 17 hours 21 minutes
Hidradenitis Suppurativa: Advances in Optimising Outcomes for Patients
Hidradenitis Suppurativa: Advances in Optimising Outcomes for Patients
COPD Exacerbations and the Evolving Role of Triple Therapy
COPD Exacerbations and the Evolving Role of Triple Therapy
Journal Club: Deciphering the Latest Data to Improve DME Treatment Choice
Journal Club: Deciphering the Latest Data to Improve DME Treatment Choice
Emerging Approaches to Early and Sustained Treatment in Schizophrenia: The Role of Second-Generation Long-Acting Injectable Antipsychotics
Go online to www.peervoice.com/h/pvr284 to view the entire programme with slides.
Journal Club: Deciphering the Latest Data to Improve DME Treatment Choice
Journal Club: Deciphering the Latest Data to Improve DME Treatment Choice
COPD Journal Club: A Paradigm Shift for the Use of Dual Bronchodilation
COPD Journal Club: A Paradigm Shift for the Use of Dual Bronchodilation
Idiopathic Pulmonary Fibrosis: Diagnose Early to Treat Effectively
Idiopathic Pulmonary Fibrosis: Diagnose Early to Treat Effectively
Journal Club on Stroke Prevention in Atrial Fibrillation: Digging Deeper Into Clinical Trial Data for Non–Vitamin K Oral Anticoagulants
Go online to www.peervoice.com/h/pvj29 to view the entire programme with slides.
Improving Outcomes in Patients With HR+ Advanced Breast Cancer: What is the Role of Dual Blockade?
Go online to www.peervoice.com/h/pvr262 to view the entire programme with slides.
Haematologic Malignancies: A Look at the Evolving Landscape of CML, AML, and PV
Haematologic Malignancies: A Look at the Evolving Landscape of CML, AML, and PV